Argentina Fines Ferring: Privacy Wake-Up Call for Pharma
In a precedent-setting decision, Argentina’s Data Protection Authority (Agencia de Acceso a la Información Pública – AAIP) has fined...
Diana Andrade
Privacy by Design in Global Clinical Trials
Multinational clinical trials are crucial for advancing medical innovation and improving patient outcomes. By including diverse populations, they provide...
Synthetic Data: A Real Fix for Clinical Trials?
The industry loves to celebrate synthetic data as a privacy solution—but where’s the real impact? Let’s be clear: privacy...
GDPR and Cross-Border Data Transfers in Clinical Trials
Cross-border data transfers are a critical yet complex aspect in clinical trials. With global collaborations becoming the norm, personal...
Ensuring Data Security Throughout the Trial Lifecycle
Clinical trials rely on robust data security measures to protect sensitive participant information, including personally identifiable information (PII) and...
Data Minimization: Balancing GDPR & Research Insights
Data minimization is one of the fundamental principles of the General Data Protection Regulation (GDPR), aimed at ensuring that...
Top 3 GDPR Compliance Questions in Clinical Trials
In the fast-evolving world of clinical trials, GDPR compliance is more than a legal obligation—it’s a pillar of trust,...
Dynamic Consent: A New GDPR Standard for Clinical Trials
In an era where data is the cornerstone of innovation, the concept of dynamic consent is emerging as a...
Navigating IP in Clinical Trials: Insights from Joana Piriquito Santos
In the high-stakes world of pharmaceuticals, intellectual property (IP) rights are crucial for protecting innovation and ensuring returns on...
GDPR Class Actions: Compliance now for Trial Sponsors
On December 1, 2024, the European non-profit organization noyb (None of Your Business), co-founded by privacy advocate Max Schrems,...